Question Bank › Backlog of demand the company cannot yet serve

Backlog of demand the company cannot yet serve

Calls Tested
495
Answered YES
32
Hit Rate
6.5%
rare by design

Gates Industrial Corporation plc (GTES) — this company's answers

YES on the Q4 2021 call 2022-02-07 C+

← Back to the full GTES analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management indicate that the company is currently CONSTRAINED ON THE SUPPLY SIDE rather than on the demand side — that is, that the binding limit on how much business it can do right now is its own ability to produce, staff, deliver, install, or fulfill, and that real, identified demand is sitting unserved, waiting, deferred, or being turned away as a result? Answer YES when management's own framing conveys that orders, customers, patients, projects, applications, or units are waiting in line ahead of the company's capability to serve them — for example describing work waiting to be delivered, wait times or lead times that have lengthened, business they had to decline, defer, or ration, hiring or facilities as the gating factor on growth, or output being sold out or fully allocated — and when management treats this shortfall of capability, not weak demand, as the main thing standing between today's results and a materially larger business. The constraint may take whatever form fits the business (people, plant, parts, licenses, space, installation crews, clinical sites, distribution, etc.). Answer NO if the company's limiting factor is described as winning demand, competition, pricing, or macro softness; NO if any bottleneck is minor, transitory, purely logistical, or already resolved and not presented as holding back the business; NO if management is chiefly discussing underutilized capacity, cost reduction, or right-sizing; NO if the shortfall is only feared for the future rather than being experienced now; and NO if the idea appears only in an analyst's question and management does not affirm it. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
KOPN Kopin Corporation Q4 2023 2024-03-14 C+
BRBR BellRing Brands, Inc. Q4 2023 2023-11-21 B+
DAL Delta Air Lines, Inc. Q2 2023 2023-07-13 A
PRPH ProPhase Labs, Inc. Q1 2023 2023-05-11 F
KE Kimball Electronics, Inc. Q3 2023 2023-05-06 C+
TACT TransAct Technologies Incorporated Q4 2022 2023-03-08 A
PI Impinj, Inc. Q4 2022 2023-02-08 B+
SIBN SI-BONE, Inc. Q3 2022 2022-11-07 C+
CHE Chemed Corporation Q3 2022 2022-11-01 B+
CRL Charles River Laboratories International Q2 2022 2022-08-03 C
SYM Symbotic Inc. Q3 2022 2022-08-01 B+
JBHT J.B. Hunt Transport Services, Inc. Q2 2022 2022-07-19 C+
OGI OrganiGram Holdings Inc. Q3 2022 2022-07-14 B+
WHF WhiteHorse Finance, Inc. Q1 2022 2022-05-10 B+
HLIO Helios Technologies, Inc. Q1 2022 2022-05-10 C
FAT FAT Brands Inc. Q4 2021 2022-03-21 F
FLUX Flux Power Holdings, Inc. Q2 2022 2022-02-10 D
GTES Gates Industrial Corporation plc Q4 2021 2022-02-07 C+
FORM FormFactor, Inc. Q4 2021 2022-02-02 B
EXP Eagle Materials Inc. Q3 2022 2022-01-27 B
GFS GLOBALFOUNDRIES Inc. Q3 2021 2021-11-30 A
HNRG Hallador Energy Company Q3 2021 2021-11-09 C+
HY Hyster-Yale Materials Handling, Inc. Q3 2021 2021-11-06 D
LEG Leggett & Platt, Incorporated Q3 2021 2021-11-02 C
IRBT iRobot Corporation Q3 2021 2021-10-28 D
EMR Emerson Electric Co. Q3 2021 2021-08-04 B+
FSS Federal Signal Corporation Q1 2018 2018-05-12 A
AOSL Alpha and Omega Semiconductor Limited Q2 2018 2018-02-07 B
ADNT Adient plc Q1 2018 2018-01-29 D
GURE Gulf Resources, Inc. Q3 2017 2017-11-14 F
RACE Ferrari N.V. Q3 2017 2017-11-02 C+
ZBH Zimmer Biomet Holdings, Inc. Q2 2017 2017-07-30 F

More from the question bank

Growth engine outrunning the legacy coreFrom episodic transactions to committed recuFrom bespoke to repeatable playbookWorst is behind us — trough passed with currFixed-cost base already built, incremental vScarce-asset owner meeting a demand shock itAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.